Expression of 5-oxoETE receptor in prostate cancer cells: critical role in survival |
| |
Authors: | Sundaram Sathish Ghosh Jagadananda |
| |
Affiliation: | Department of Urology, Vattikuti Urology Institute, Henry Ford Health System, Detroit, MI 48202, USA. |
| |
Abstract: | Previously, we reported that metabolism of arachidonic acid through the 5-lipoxygenase (5-LOX) pathway plays an important role in the survival and growth of human prostate cancer cells. Inhibition of 5-LOX by pharmacological inhibitors triggers apoptosis in prostate cancer cells within hours of treatment, which is prevented by the metabolites of arachidonate 5-lipoxygenase, 5(S)-hydroxyeicosatetraenoic acid (5(S)-HETE), and its dehydrogenated derivative, 5-oxoeicosatetraenoic acid (5-oxoETE). These findings suggested that 5-lipoxygenase metabolites are critical survival factors of prostate cancer cells. However, molecular mechanisms by which 5(S)-HETE and its derivative 5-oxoETE exert their effects on prostate cancer cell survival are yet to be understood. Here, we report that human prostate cancer cells differentially express a G-protein-coupled 5-oxoETE receptor (5-oxoER) in them. Blocking expression of 5-oxoER by short-interfering RNA (siRNA) significantly reduced the viability of prostate cancer cells, suggesting that 5-oxoER is critical for prostate cancer cell survival, and that the 5-LOX metabolite, 5-oxoETE, controls survival of prostate cancer cells through its own G-protein-coupled receptor, 5-oxoER. |
| |
Keywords: | Arachidonic acid Prostate cancer Eicosanoids 5(S)-HETE 5-oxoETE 5-oxoER |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|